Clinical trial
Comparison Efficacy of 14-day Triple Therapy Between Clarithromycin and Levofloxacin on the Eradication of Helicobacter Pylori in Syrian Population
NCT02693574 is registered in ClinicalTrials.gov with Damascus Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison Efficacy of 14-day Triple Therapy Between Clarithromycin and Levofloxacin on the Eradication of Helicobacter Pylori in Syrian Population
- Lead sponsor
- Damascus Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 1, 2015
- Completion date
- May 31, 2017
- Enrollment
- 74 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
helicobacter pylori gastrointestinal tract infection